The third earnings season of 2025 is in full swing.
Investors will review the financial results and business updates from a wide range of companies, including REITs, blue-chip stocks, and smaller and mid-sized companies.
Businesses that report higher revenue and profits are prime candidates for inclusion in your portfolio.
However, you need to assess if the company has good business prospects that can help it to continue growing its top and bottom lines.
Here are three companies that recently reported better profits, and could be good candidates for your buy watchlist.
iFAST Corporation (SGX: AIY)
iFAST Corporation is a financial technology company that operates a platform for the buying and selling of unit trusts, equities, and bonds.
The group also owns a digital bank that offers remittance services along with products for business and personal banking.
iFAST reported a strong set of earnings for the first half of 2025 (1H 2025).
Net revenue rose 23.7% year on year to S$147.8 million, contributed by increased revenue recognition from its Hong Kong eMPF project along with a surge in interest revenue.
Operating profit jumped 32.7% year on year to S$51.2 million, and net profit shot up 34.7% year on year to S$41.1 million.
Meanwhile, the fintech group’s assets under administration (AUA) also reached a record of S$27.2 billion, up 21.6% year on year.
This AUA was boosted by a record net inflow of S$1.29 billion for the second quarter of 2025 (2Q 2025).
For its second interim dividend, iFAST upped this to S$0.02 from S$0.015 a year ago, representing a 33% year-on-year increase.
For 2025, the directors expect the total dividend to be at least S$0.08 or higher, which translates to a year-on-year increase of 35.6% or more.
Looking ahead, iFAST expects 2H 2025’s revenue and profitability to show a marked improvement compared with 1H 2025 as the ePension division’s onboarding of trustees progresses.
Its Hong Kong business should also see double-digit net revenue and profit before tax growth in 2026.
Mandarin Oriental International (SGX: M04)
Mandarin Oriental is an owner and operator of luxury hotels, resorts, and residences.
The group operates 44 hotels, 12 residences, and 26 exclusive homes in 27 countries with more properties under development.
The group reported a solid set of results for 1H 2025 with combined total revenue rising 11% year on year to US$1.09 billion.
The underlying net profit for Mandarin Oriental rose 6% year on year to US$24 million.
The group also enjoyed an 11% year-on-year increase in revenue per available room (RevPAR).
The group kept its interim dividend constant at US$0.015.
Two hotels and residences and one residence are scheduled to open in 2H 2025, helping to expand the group’s portfolio further.
Despite the ongoing geopolitical instability, Mandarin Oriental is confident that the group is well-positioned to capitalise on the sustained demand for luxury leisure travel.
Raffles Medical Group (SGX: BSL)
Raffles Medical Group, or RMG, is an integrated healthcare provider with a network of four hospitals and over 100 multi-disciplinary clinics.
These hospitals and clinics offer a wide range of services such as health screening, specialist care, diagnostic services, and dental services.
The healthcare group saw revenue rise 3.5% year on year to S$378.4 million for 1H 2025
Operating profit inched up 0.8% year on year to S$41.6 million while net profit increased by 4.8% year on year to S$32.1 million.
Free cash flow soared 139% year on year, going from S$21.7 million to S$52 million.
RMG’s Healthcare Services and Hospital Services divisions both saw year-on-year revenue increases.
However, Healthcare Services’ segment profit fell year on year to S$24.9 million from S$27.6 million.
Over in China, revenue increased marginally in local terms but fell slightly when translated to Singapore dollars because of the weaker RMB.
The revenue increase was attributed to the Raffles Hospital brand gaining wider recognition and trust among the Chinese as a quality healthcare provider.
Cost-savings measures put in place also helped to reduce the initial start-up losses for RMG’s hospitals in both Chongqing and Shanghai.
RMG continued to forge partnerships with Chinese hospitals to provide high-quality healthcare services to a wider group of patients.
In March and June, the group signed strategic partnerships with Shanghai’s Renji Hospital and Chongqing’s First Affiliated Hospital, respectively.
These partnerships help integrate international standards with local expertise and can help to drive medical innovation and deliver a higher quality of care.
Don’t let market uncertainty hijack your financial dreams. While headlines scream gloom, 5 Singapore companies have been quietly building wealth and paying reliable dividends. You’re probably overlooking them. Discover these resilient giants and their secrets to sustained income, even through global storms. Click here to download your free report now and secure your financial future!
Follow us on Facebook, Instagram and Telegram for the latest investing news and analyses!
Disclosure: Royston Yang owns shares of iFAST Corporation and Raffles Medical Group.
